AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Jul 6, 2015
29828_dirs_2015-07-06_96d8a8f2-d94c-4364-8425-aee966e74eee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-07-01
Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-01 | Common Stock | M | 150000 | $14.5025 | Acquired | 4364492 | Direct |
| 2015-07-01 | Common Stock | S | 92260 | $115.9184 | Disposed | 4272232 | Direct |
| 2015-07-01 | Common Stock | S | 41115 | $117.0646 | Disposed | 4231117 | Direct |
| 2015-07-01 | Common Stock | S | 16625 | $118.0101 | Disposed | 4214492 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-01 | Non-Qualified Stock option (right to buy) | $14.5025 | M | 150000 | Disposed | 2016-01-25 | Common Stock (150000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $115.46 to $116.43. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $116.58 to $117.58. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $117.59 to $118.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: The number of shares reported as direct holdings reflects the correction of a past overstatement of 41,384 shares arising from a pre-2003 administrative reporting error. Stock splits in Sep 2004, June 2007 and Jan 2013 increased the original 5,173 share reporting error to 41,384 shares.